Altamira Therapeutics

Altamira Therapeutics is focused on developing innovative pharmaceutical therapies aimed at addressing unmet medical needs, particularly in neurotologic disorders affecting the inner ear. The company is recognized as a pioneer in creating treatments for hearing protection, tinnitus relief, and balance restoration. Among its product offerings is Bentrio, a drug-free nasal spray designed to provide personal protection against airborne viruses and allergens. Additionally, Altamira utilizes its OligoPhore/SemaPhore platform, which enables the complexation of therapeutic RNAs with proprietary peptides to create nanoparticle formulations. This technology facilitates the systemic delivery of therapeutic RNA to tissues impacted by leaky vasculature, which is characteristic of solid tumors and certain inflammatory conditions.